Not Yet RecruitingNot Applicable

Comparison of Goniotomy Device Outcomes in Combined Phacoemulsification-goniotomy Surgeries

United States132 participantsStarted 2026-03-01

Plain-language summary

The goal of this study is to determine of one of three different devices to perform goniotomy to treat glaucoma at the time of cataract surgery is more or less effective than the others. The primary outcomes are to compare intraocular pressure control and glaucoma medication use up to 6 months after surgery. Participants will under combined cataract surgery and goniotomy. They will have post-operative follow up visits at 1 day, 1 week, 1 month, 3 months, and 6 month

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Adults ≥ 18 years old * Diagnosed with primary or secondary open-angle glaucoma (e.g., POAG, pigmentary, pseudoexfoliative) * Scheduled for phacoemulsification with planned goniotomy * Able to provide informed consent Exclusion Criteria: * Angle-closure glaucoma * Prior glaucoma surgery in the study eye * Planned stand-alone goniotomy * Inability to comply with follow-up schedule

What they're measuring

Intraocular pressure

Timeframe: up to 6 months

Medications

Timeframe: up to 6 months

Visual Acuity

Timeframe: up to 6 months

Trial details

NCT IDNCT07418853

SponsorHenry Ford Health System

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2028-03-01

Contact for this trial

David A Crandall, MD

248-661-5100 dcranda1@hfhs.org

View on ClinicalTrials.gov More Open Angle Glaucoma (OAG) trials